Clinical Trial Update: RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65

View source ↗

Summary

The RESILIENCE trial evaluating the durability of RESILIA tissue aortic bioprostheses in subjects under 65 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• RESILIA Tissue Aortic Bioprosthesis

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Replacement | Status: TERMINATED